Xbrane Biopharma (Sweden) Technical Analysis
| XBRANE Stock | SEK 0.17 0.01 6.25% |
As of the 20th of January, Xbrane Biopharma maintains the Standard Deviation of 4.24, mean deviation of 2.84, and Market Risk Adjusted Performance of (4.18). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xbrane Biopharma AB, as well as the relationship between them.
Xbrane Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Xbrane, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to XbraneXbrane |
Xbrane Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Xbrane Biopharma Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Xbrane Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Xbrane Biopharma Trend Analysis
Use this graph to draw trend lines for Xbrane Biopharma AB. You can use it to identify possible trend reversals for Xbrane Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Xbrane Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Xbrane Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Xbrane Biopharma AB applied against its price change over selected period. The best fit line has a slop of 0.0011 , which may suggest that Xbrane Biopharma AB market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.04, which is the sum of squared deviations for the predicted Xbrane Biopharma price change compared to its average price change.About Xbrane Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Xbrane Biopharma AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Xbrane Biopharma AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Xbrane Biopharma price pattern first instead of the macroeconomic environment surrounding Xbrane Biopharma. By analyzing Xbrane Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Xbrane Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Xbrane Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Xbrane Biopharma January 20, 2025 Technical Indicators
Most technical analysis of Xbrane help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Xbrane from various momentum indicators to cycle indicators. When you analyze Xbrane charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (4.18) | |||
| Mean Deviation | 2.84 | |||
| Coefficient Of Variation | (1,243) | |||
| Standard Deviation | 4.24 | |||
| Variance | 17.94 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (4.19) | |||
| Maximum Drawdown | 20.05 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 5.88 | |||
| Skewness | 0.3507 | |||
| Kurtosis | 0.9708 |
Complementary Tools for Xbrane Stock analysis
When running Xbrane Biopharma's price analysis, check to measure Xbrane Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xbrane Biopharma is operating at the current time. Most of Xbrane Biopharma's value examination focuses on studying past and present price action to predict the probability of Xbrane Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xbrane Biopharma's price. Additionally, you may evaluate how the addition of Xbrane Biopharma to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets |